Librede Inc Profile last edited on: 9/17/2018
CAGE: 597Q8
UEI: PJT7RZNNX664
Business Identifier: High Quality Pharmaceuticals from Yeast 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
570 Westwood Plaza Cnsi Room 1225
Los Angeles, CA 90095
Los Angeles, CA 90095
| (818) 835-5432 |
| poulos@librede.com |
| www.librede.com |
Location: Single
Congr. District: 36
County: Los Angeles
Congr. District: 36
County: Los Angeles
Public Profile
With their defined mission being that of improving the quality of life through innovated sustainable technologies, Librede Inc. is organized around development of platform technologies that enable the creation of new therapeutics. Librede has developed a new yeast-based technology that can produce cannabinoids from low cost starting materials like sugar in a more environmentally friendly way, utilizing a fraction of the water and land and with no fertilizers or pesticides. Librede's technology can also produce cannabinoids produced in ultra-low abundance in plants, providing a low cost source of material for pharmaceutical studies.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
15-19Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2019 | 2 | NIH | $1,719,421 | |
| Project Title: Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products | ||||
| 2016 | 1 | NIH | $224,920 | |
| Project Title: Development of a Cannabinoid Yeast Factory: Improving Geranyl Pyrophosphate Production Through Metabolic Engineering | ||||
| 2015 | 1 | NIH | $224,637 | |
| Project Title: Automated Nanopore Platform for Microrna Based Diagnostics | ||||
| 2014 | 2 | NIH | $1,300,069 | |
| Project Title: Droplet-Based Artificial Membrane Technology for High Throughput Cell-Free Ion Ch | ||||
| 2014 | 2 | NIH | $1,681,163 | |
| Project Title: Instrumentation Development for Parallel Measurement of an Ion Channel Array Chip | ||||
Key People / Management
Jason L Poulos -- Founder and CEO
Anthony N Farina
Jacob Schmidt -- Founder
Anthony N Farina
Jacob Schmidt -- Founder
Company News
There are no news available.
